01 4Prevymis
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 281
2019 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 370
2020 Revenue in Millions : 281
Growth (%) : 32
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 428
2021 Revenue in Millions : 370
Growth (%) : 16
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 605
2022 Revenue in Millions : 428
Growth (%) : 41
LOOKING FOR A SUPPLIER?